September 24, 2018
MMC Awarded $1.1M for Multi-Center Study
Dr. Jonathan Zuckerman, Lead Principal Investigator at Maine Medical Center
The Cystic Fibrosis (CF) Foundation recently awarded MMC $1.1M for a multi-center study investigating complications associated with use of midline and peripherally inserted central venous catheters (PICCs) in CF patients. CF is a progressive, genetic disease that causes lung infections which often require repeated courses of intravenous (IV) antibiotics through PICCs or midline catheters. A range of adverse events such as clots, infection and permanent distortion of blood vessels can arise from use of these catheters. Identifying risk factors for these complications should help health care providers prevent injury and improve overall outcomes in this vulnerable population. Jonathan Zuckerman, MD, Maine Medical Center, and Alex Gifford, MD, Dartmouth-Hitchcock Medical Center, are the lead principal investigators for the project.
“To date, no multi-center study has carefully investigated these complications in a large, diverse group of adult and pediatric CF patients,” says Dr. Zuckerman. “We are excited to leverage the resources and talents available through Maine Medical Center Research Institute to coordinate such a large effort.” The study will include 10 sites across the United States over three years.